Enviar búsqueda
Cargar
Q3 2009 Earning Report of Walgreen Co.
•
0 recomendaciones
•
736 vistas
E
earningreport earningreport
Seguir
Relaciones con inversores
Salud y medicina
Denunciar
Compartir
Denunciar
Compartir
1 de 41
Descargar ahora
Descargar para leer sin conexión
Recomendados
textron annual report 2000
textron annual report 2000
finance21
Nestle ru2 qcy2010-02-08-10
Nestle ru2 qcy2010-02-08-10
Angel Broking
Dow Accelerates Implementation of its Transformational Strategy Presentation
Dow Accelerates Implementation of its Transformational Strategy Presentation
finance5
Non-Deal Roadshow'
Non-Deal Roadshow'
CPFL RI
monsanto 02-13-07
monsanto 02-13-07
finance28
Monsanto Q2 2007 Financial Results
Monsanto Q2 2007 Financial Results
earningsreport
Colgate Palmolive
Colgate Palmolive
Angel Broking
Honeywell Q4 2008 Earnings Conference Call Presentation
Honeywell Q4 2008 Earnings Conference Call Presentation
finance8
Recomendados
textron annual report 2000
textron annual report 2000
finance21
Nestle ru2 qcy2010-02-08-10
Nestle ru2 qcy2010-02-08-10
Angel Broking
Dow Accelerates Implementation of its Transformational Strategy Presentation
Dow Accelerates Implementation of its Transformational Strategy Presentation
finance5
Non-Deal Roadshow'
Non-Deal Roadshow'
CPFL RI
monsanto 02-13-07
monsanto 02-13-07
finance28
Monsanto Q2 2007 Financial Results
Monsanto Q2 2007 Financial Results
earningsreport
Colgate Palmolive
Colgate Palmolive
Angel Broking
Honeywell Q4 2008 Earnings Conference Call Presentation
Honeywell Q4 2008 Earnings Conference Call Presentation
finance8
Dishman
Dishman
Angel Broking
monsanto 02-21-06
monsanto 02-21-06
finance28
csx Citigroup11.06.07
csx Citigroup11.06.07
finance27
terex Shareholders0508
terex Shareholders0508
finance42
Ranbaxy Result Update 1qcy2010-120510
Ranbaxy Result Update 1qcy2010-120510
Angel Broking
Investment Idea - POLYPLEX CORPORATION LTD - "BUY"
Investment Idea - POLYPLEX CORPORATION LTD - "BUY"
Fullerton Securities
H.C. Shin Executive Vice President, Industrial and Transportation Business
H.C. Shin Executive Vice President, Industrial and Transportation Business
finance10
Conference Call Presentation 4Q09
Conference Call Presentation 4Q09
Tempo
Investment Idea - BPCL : Recommended as "Sell"
Investment Idea - BPCL : Recommended as "Sell"
Fullerton Securities
Financial report 2010 taj pharmaceuticals group
Financial report 2010 taj pharmaceuticals group
Shantanu Singh
terex Sanford053008
terex Sanford053008
finance42
terex KeyBanc060508
terex KeyBanc060508
finance42
Q1 2009 Earning Report of Juniper Networks Inc.
Q1 2009 Earning Report of Juniper Networks Inc.
earningreport earningreport
Mahindra & Mahindra
Mahindra & Mahindra
Angel Broking
Software Configuration Management And CVS
Software Configuration Management And CVS
Rajesh Kumar
Employer Information Session: Coram/CVS Health
Employer Information Session: Coram/CVS Health
TridentCADC
walgreen Lehman Brothers Eleventh Annual Retail and
walgreen Lehman Brothers Eleventh Annual Retail and
finance4
Proyecto Empresarial – Clase 03 – Dimensiones de un mercado. Los círculos dor...
Proyecto Empresarial – Clase 03 – Dimensiones de un mercado. Los círculos dor...
LEOnardo AMARaldo DELgado
Marketing strategies for cvs pharmacy
Marketing strategies for cvs pharmacy
Yuanping Hu
Mastering Controlled Vocabularies (CVs) to faciliate succesful Regulatory Inf...
Mastering Controlled Vocabularies (CVs) to faciliate succesful Regulatory Inf...
Qdossier B.V.
STEELMAKING TECHNOLOGIES AND NEW INNOVATIONS IN MELTSHOPS - CVS MAKINA
STEELMAKING TECHNOLOGIES AND NEW INNOVATIONS IN MELTSHOPS - CVS MAKINA
metudgn
CVS Shopping Guide - How To Extreme Coupon at CVS
CVS Shopping Guide - How To Extreme Coupon at CVS
Chrystie Vachon
Más contenido relacionado
La actualidad más candente
Dishman
Dishman
Angel Broking
monsanto 02-21-06
monsanto 02-21-06
finance28
csx Citigroup11.06.07
csx Citigroup11.06.07
finance27
terex Shareholders0508
terex Shareholders0508
finance42
Ranbaxy Result Update 1qcy2010-120510
Ranbaxy Result Update 1qcy2010-120510
Angel Broking
Investment Idea - POLYPLEX CORPORATION LTD - "BUY"
Investment Idea - POLYPLEX CORPORATION LTD - "BUY"
Fullerton Securities
H.C. Shin Executive Vice President, Industrial and Transportation Business
H.C. Shin Executive Vice President, Industrial and Transportation Business
finance10
Conference Call Presentation 4Q09
Conference Call Presentation 4Q09
Tempo
Investment Idea - BPCL : Recommended as "Sell"
Investment Idea - BPCL : Recommended as "Sell"
Fullerton Securities
Financial report 2010 taj pharmaceuticals group
Financial report 2010 taj pharmaceuticals group
Shantanu Singh
terex Sanford053008
terex Sanford053008
finance42
terex KeyBanc060508
terex KeyBanc060508
finance42
Q1 2009 Earning Report of Juniper Networks Inc.
Q1 2009 Earning Report of Juniper Networks Inc.
earningreport earningreport
Mahindra & Mahindra
Mahindra & Mahindra
Angel Broking
La actualidad más candente
(14)
Dishman
Dishman
monsanto 02-21-06
monsanto 02-21-06
csx Citigroup11.06.07
csx Citigroup11.06.07
terex Shareholders0508
terex Shareholders0508
Ranbaxy Result Update 1qcy2010-120510
Ranbaxy Result Update 1qcy2010-120510
Investment Idea - POLYPLEX CORPORATION LTD - "BUY"
Investment Idea - POLYPLEX CORPORATION LTD - "BUY"
H.C. Shin Executive Vice President, Industrial and Transportation Business
H.C. Shin Executive Vice President, Industrial and Transportation Business
Conference Call Presentation 4Q09
Conference Call Presentation 4Q09
Investment Idea - BPCL : Recommended as "Sell"
Investment Idea - BPCL : Recommended as "Sell"
Financial report 2010 taj pharmaceuticals group
Financial report 2010 taj pharmaceuticals group
terex Sanford053008
terex Sanford053008
terex KeyBanc060508
terex KeyBanc060508
Q1 2009 Earning Report of Juniper Networks Inc.
Q1 2009 Earning Report of Juniper Networks Inc.
Mahindra & Mahindra
Mahindra & Mahindra
Destacado
Software Configuration Management And CVS
Software Configuration Management And CVS
Rajesh Kumar
Employer Information Session: Coram/CVS Health
Employer Information Session: Coram/CVS Health
TridentCADC
walgreen Lehman Brothers Eleventh Annual Retail and
walgreen Lehman Brothers Eleventh Annual Retail and
finance4
Proyecto Empresarial – Clase 03 – Dimensiones de un mercado. Los círculos dor...
Proyecto Empresarial – Clase 03 – Dimensiones de un mercado. Los círculos dor...
LEOnardo AMARaldo DELgado
Marketing strategies for cvs pharmacy
Marketing strategies for cvs pharmacy
Yuanping Hu
Mastering Controlled Vocabularies (CVs) to faciliate succesful Regulatory Inf...
Mastering Controlled Vocabularies (CVs) to faciliate succesful Regulatory Inf...
Qdossier B.V.
STEELMAKING TECHNOLOGIES AND NEW INNOVATIONS IN MELTSHOPS - CVS MAKINA
STEELMAKING TECHNOLOGIES AND NEW INNOVATIONS IN MELTSHOPS - CVS MAKINA
metudgn
CVS Shopping Guide - How To Extreme Coupon at CVS
CVS Shopping Guide - How To Extreme Coupon at CVS
Chrystie Vachon
Version Control With CVS
Version Control With CVS
Rajesh Kumar
MGT 450 Final Presentation Walgreens
MGT 450 Final Presentation Walgreens
Shivam Shah
History & physical examination of cvs
History & physical examination of cvs
Mandeep Duarah
Presentation on 4 p's
Presentation on 4 p's
moadeogun
Destacado
(12)
Software Configuration Management And CVS
Software Configuration Management And CVS
Employer Information Session: Coram/CVS Health
Employer Information Session: Coram/CVS Health
walgreen Lehman Brothers Eleventh Annual Retail and
walgreen Lehman Brothers Eleventh Annual Retail and
Proyecto Empresarial – Clase 03 – Dimensiones de un mercado. Los círculos dor...
Proyecto Empresarial – Clase 03 – Dimensiones de un mercado. Los círculos dor...
Marketing strategies for cvs pharmacy
Marketing strategies for cvs pharmacy
Mastering Controlled Vocabularies (CVs) to faciliate succesful Regulatory Inf...
Mastering Controlled Vocabularies (CVs) to faciliate succesful Regulatory Inf...
STEELMAKING TECHNOLOGIES AND NEW INNOVATIONS IN MELTSHOPS - CVS MAKINA
STEELMAKING TECHNOLOGIES AND NEW INNOVATIONS IN MELTSHOPS - CVS MAKINA
CVS Shopping Guide - How To Extreme Coupon at CVS
CVS Shopping Guide - How To Extreme Coupon at CVS
Version Control With CVS
Version Control With CVS
MGT 450 Final Presentation Walgreens
MGT 450 Final Presentation Walgreens
History & physical examination of cvs
History & physical examination of cvs
Presentation on 4 p's
Presentation on 4 p's
Similar a Q3 2009 Earning Report of Walgreen Co.
Walgreen Co. First Quarter 2009 Earnings Conference
Walgreen Co. First Quarter 2009 Earnings Conference
finance4
meadwestvaco 4Q07_Earnings_Slides
meadwestvaco 4Q07_Earnings_Slides
finance33
meadwestvaco 4Q07_Earnings_Slides
meadwestvaco 4Q07_Earnings_Slides
finance33
Honeywell Q4 2008 Earnings Conference Call Presentation
Honeywell Q4 2008 Earnings Conference Call Presentation
finance8
Honeywell Download Documentation Q4 2008 Earnings Conference Call Presentation
Honeywell Download Documentation Q4 2008 Earnings Conference Call Presentation
finance8
Patrick D. Campbell, Senior Vice President and CFO
Patrick D. Campbell, Senior Vice President and CFO
finance10
monsanto 04-04-07
monsanto 04-04-07
finance28
.monsanto 04-04-07
.monsanto 04-04-07
finance28
Investor Conference 2008
Investor Conference 2008
finance7
Q1 2009 Earning Report of Banco Santander
Q1 2009 Earning Report of Banco Santander
earningreport earningreport
Q1 2009 Earning Report of Banco Santander
Q1 2009 Earning Report of Banco Santander
earningreport earningreport
monsanto 01-08-08
monsanto 01-08-08
finance28
monsanto 01-08-08
monsanto 01-08-08
finance28
monsanto 01-08-08
monsanto 01-08-08
finance28
kellogg annual reports 2008
kellogg annual reports 2008
finance23
George W. Buckley Presentation
George W. Buckley Presentation
finance10
ppl annual reports 2006
ppl annual reports 2006
finance32
Q3 2009 Earning Report of Jean Coutu Group
Q3 2009 Earning Report of Jean Coutu Group
earningreport earningreport
metlife Investor Day 2008 Individual
metlife Investor Day 2008 Individual
finance5
csx Citigroup11.06.07
csx Citigroup11.06.07
finance27
Similar a Q3 2009 Earning Report of Walgreen Co.
(20)
Walgreen Co. First Quarter 2009 Earnings Conference
Walgreen Co. First Quarter 2009 Earnings Conference
meadwestvaco 4Q07_Earnings_Slides
meadwestvaco 4Q07_Earnings_Slides
meadwestvaco 4Q07_Earnings_Slides
meadwestvaco 4Q07_Earnings_Slides
Honeywell Q4 2008 Earnings Conference Call Presentation
Honeywell Q4 2008 Earnings Conference Call Presentation
Honeywell Download Documentation Q4 2008 Earnings Conference Call Presentation
Honeywell Download Documentation Q4 2008 Earnings Conference Call Presentation
Patrick D. Campbell, Senior Vice President and CFO
Patrick D. Campbell, Senior Vice President and CFO
monsanto 04-04-07
monsanto 04-04-07
.monsanto 04-04-07
.monsanto 04-04-07
Investor Conference 2008
Investor Conference 2008
Q1 2009 Earning Report of Banco Santander
Q1 2009 Earning Report of Banco Santander
Q1 2009 Earning Report of Banco Santander
Q1 2009 Earning Report of Banco Santander
monsanto 01-08-08
monsanto 01-08-08
monsanto 01-08-08
monsanto 01-08-08
monsanto 01-08-08
monsanto 01-08-08
kellogg annual reports 2008
kellogg annual reports 2008
George W. Buckley Presentation
George W. Buckley Presentation
ppl annual reports 2006
ppl annual reports 2006
Q3 2009 Earning Report of Jean Coutu Group
Q3 2009 Earning Report of Jean Coutu Group
metlife Investor Day 2008 Individual
metlife Investor Day 2008 Individual
csx Citigroup11.06.07
csx Citigroup11.06.07
Más de earningreport earningreport
Q3 2009 Earning Report of Banco Santander S.A.
Q3 2009 Earning Report of Banco Santander S.A.
earningreport earningreport
Q3 Earning report of Daimler AG
Q3 Earning report of Daimler AG
earningreport earningreport
Q3 Earning Report of BB&T Corporation
Q3 Earning Report of BB&T Corporation
earningreport earningreport
Q3 Earning Report of BB&T Corporation
Q3 Earning Report of BB&T Corporation
earningreport earningreport
Q3 2009 Earning Report of Brown & Brown
Q3 2009 Earning Report of Brown & Brown
earningreport earningreport
Q3 2009 Earning Report of Boston Scientific Corporation
Q3 2009 Earning Report of Boston Scientific Corporation
earningreport earningreport
Q3 2009 Earning Report of Boston Scientific Corporation
Q3 2009 Earning Report of Boston Scientific Corporation
earningreport earningreport
Q3 2009 Earning Report of Atheros Communications, Inc.
Q3 2009 Earning Report of Atheros Communications, Inc.
earningreport earningreport
Q3 2009 Earning Report of Apple Inc.
Q3 2009 Earning Report of Apple Inc.
earningreport earningreport
Q3 2009 Earning Report of Hancock Holding Company
Q3 2009 Earning Report of Hancock Holding Company
earningreport earningreport
Q3 2009 Earning Report of Infosys Technologies Ltd.
Q3 2009 Earning Report of Infosys Technologies Ltd.
earningreport earningreport
Q3 2009 Earning Report of Marriott International
Q3 2009 Earning Report of Marriott International
earningreport earningreport
Q3 2009 Earning Report of PepsiCo.
Q3 2009 Earning Report of PepsiCo.
earningreport earningreport
Q3 2009 Earning Report of Alcoa, Inc.
Q3 2009 Earning Report of Alcoa, Inc.
earningreport earningreport
Q3 2009 Earning Report of Pepsi Bottling Group
Q3 2009 Earning Report of Pepsi Bottling Group
earningreport earningreport
Q3 2009 Earning Report of Minerva plc
Q3 2009 Earning Report of Minerva plc
earningreport earningreport
Q3 2009 Earning Report of Worthington Industries, Inc.
Q3 2009 Earning Report of Worthington Industries, Inc.
earningreport earningreport
Q3 2009 Earning Report of Walgreen
Q3 2009 Earning Report of Walgreen
earningreport earningreport
Q3 2009 Earning Report of Trc Companies Inc.
Q3 2009 Earning Report of Trc Companies Inc.
earningreport earningreport
Q3 2009 Earning Report of The Mosaic Company
Q3 2009 Earning Report of The Mosaic Company
earningreport earningreport
Más de earningreport earningreport
(20)
Q3 2009 Earning Report of Banco Santander S.A.
Q3 2009 Earning Report of Banco Santander S.A.
Q3 Earning report of Daimler AG
Q3 Earning report of Daimler AG
Q3 Earning Report of BB&T Corporation
Q3 Earning Report of BB&T Corporation
Q3 Earning Report of BB&T Corporation
Q3 Earning Report of BB&T Corporation
Q3 2009 Earning Report of Brown & Brown
Q3 2009 Earning Report of Brown & Brown
Q3 2009 Earning Report of Boston Scientific Corporation
Q3 2009 Earning Report of Boston Scientific Corporation
Q3 2009 Earning Report of Boston Scientific Corporation
Q3 2009 Earning Report of Boston Scientific Corporation
Q3 2009 Earning Report of Atheros Communications, Inc.
Q3 2009 Earning Report of Atheros Communications, Inc.
Q3 2009 Earning Report of Apple Inc.
Q3 2009 Earning Report of Apple Inc.
Q3 2009 Earning Report of Hancock Holding Company
Q3 2009 Earning Report of Hancock Holding Company
Q3 2009 Earning Report of Infosys Technologies Ltd.
Q3 2009 Earning Report of Infosys Technologies Ltd.
Q3 2009 Earning Report of Marriott International
Q3 2009 Earning Report of Marriott International
Q3 2009 Earning Report of PepsiCo.
Q3 2009 Earning Report of PepsiCo.
Q3 2009 Earning Report of Alcoa, Inc.
Q3 2009 Earning Report of Alcoa, Inc.
Q3 2009 Earning Report of Pepsi Bottling Group
Q3 2009 Earning Report of Pepsi Bottling Group
Q3 2009 Earning Report of Minerva plc
Q3 2009 Earning Report of Minerva plc
Q3 2009 Earning Report of Worthington Industries, Inc.
Q3 2009 Earning Report of Worthington Industries, Inc.
Q3 2009 Earning Report of Walgreen
Q3 2009 Earning Report of Walgreen
Q3 2009 Earning Report of Trc Companies Inc.
Q3 2009 Earning Report of Trc Companies Inc.
Q3 2009 Earning Report of The Mosaic Company
Q3 2009 Earning Report of The Mosaic Company
Último
Pakistani Call girls in Ajman +971563133746 Ajman Call girls
Pakistani Call girls in Ajman +971563133746 Ajman Call girls
gwenoracqe6
(INDIRA) Call Girl Kashmir Call Now 8617697112 Kashmir Escorts 24x7
(INDIRA) Call Girl Kashmir Call Now 8617697112 Kashmir Escorts 24x7
Call Girls in Nagpur High Profile Call Girls
VVIP Pune Call Girls Handewadi WhatSapp Number 8005736733 With Elite Staff An...
VVIP Pune Call Girls Handewadi WhatSapp Number 8005736733 With Elite Staff An...
SUHANI PANDEY
SME IPO and sme ipo listing consultants .pptx
SME IPO and sme ipo listing consultants .pptx
india IPO
Teck Investor Presentation, April 24, 2024
Teck Investor Presentation, April 24, 2024
TeckResourcesLtd
Q3 FY24 Earnings Conference Call Presentation
Q3 FY24 Earnings Conference Call Presentation
Sysco_Investors
VIP Call Girls Mehsana 7001035870 Whatsapp Number, 24/07 Booking
VIP Call Girls Mehsana 7001035870 Whatsapp Number, 24/07 Booking
dharasingh5698
Call Girls 🫤 Hauz Khas ➡️ 9999965857 ➡️ Delhi 🫦 Russian Escorts FULL ENJOY
Call Girls 🫤 Hauz Khas ➡️ 9999965857 ➡️ Delhi 🫦 Russian Escorts FULL ENJOY
Call Girls In Delhi Whatsup 9873940964 Enjoy Unlimited Pleasure
Nicola Mining Inc. Corporate Presentation May 2024
Nicola Mining Inc. Corporate Presentation May 2024
nicola_mining
Corporate Presentation Probe May 2024.pdf
Corporate Presentation Probe May 2024.pdf
Probe Gold
VIP Amritsar Call Girl 7001035870 Enjoy Call Girls With Our Escorts
VIP Amritsar Call Girl 7001035870 Enjoy Call Girls With Our Escorts
sonatiwari757
(👉゚9999965857 ゚)👉 VIP Call Girls Friends Colony 👉 Delhi 👈 : 9999 Cash Payment...
(👉゚9999965857 ゚)👉 VIP Call Girls Friends Colony 👉 Delhi 👈 : 9999 Cash Payment...
Call Girls In Delhi Whatsup 9873940964 Enjoy Unlimited Pleasure
Call Girls In Amritsar 💯Call Us 🔝 76967 34778🔝 💃 Independent Escort In Amritsar
Call Girls In Amritsar 💯Call Us 🔝 76967 34778🔝 💃 Independent Escort In Amritsar
only4webmaster01
Indapur - Virgin Call Girls Pune | Whatsapp No 8005736733 VIP Escorts Service...
Indapur - Virgin Call Girls Pune | Whatsapp No 8005736733 VIP Escorts Service...
SUHANI PANDEY
Vip Call Girls South Ex ➡️ Delhi ➡️ 9999965857 No Advance 24HRS Live
Vip Call Girls South Ex ➡️ Delhi ➡️ 9999965857 No Advance 24HRS Live
Call Girls In Delhi Whatsup 9873940964 Enjoy Unlimited Pleasure
Vip Call Girls Vasant Kunj ➡️ Delhi ➡️ 9999965857 No Advance 24HRS Live
Vip Call Girls Vasant Kunj ➡️ Delhi ➡️ 9999965857 No Advance 24HRS Live
Call Girls In Delhi Whatsup 9873940964 Enjoy Unlimited Pleasure
Call Girls Chandigarh Just Call 8868886958 Top Class Call Girl Service Available
Call Girls Chandigarh Just Call 8868886958 Top Class Call Girl Service Available
Sheetaleventcompany
Editing progress 20th march.docxxxxxxxxx
Editing progress 20th march.docxxxxxxxxx
MollyBrown86
Collective Mining | Corporate Presentation - April 2024
Collective Mining | Corporate Presentation - April 2024
CollectiveMining1
Collective Mining | Corporate Presentation - May 2024
Collective Mining | Corporate Presentation - May 2024
CollectiveMining1
Último
(20)
Pakistani Call girls in Ajman +971563133746 Ajman Call girls
Pakistani Call girls in Ajman +971563133746 Ajman Call girls
(INDIRA) Call Girl Kashmir Call Now 8617697112 Kashmir Escorts 24x7
(INDIRA) Call Girl Kashmir Call Now 8617697112 Kashmir Escorts 24x7
VVIP Pune Call Girls Handewadi WhatSapp Number 8005736733 With Elite Staff An...
VVIP Pune Call Girls Handewadi WhatSapp Number 8005736733 With Elite Staff An...
SME IPO and sme ipo listing consultants .pptx
SME IPO and sme ipo listing consultants .pptx
Teck Investor Presentation, April 24, 2024
Teck Investor Presentation, April 24, 2024
Q3 FY24 Earnings Conference Call Presentation
Q3 FY24 Earnings Conference Call Presentation
VIP Call Girls Mehsana 7001035870 Whatsapp Number, 24/07 Booking
VIP Call Girls Mehsana 7001035870 Whatsapp Number, 24/07 Booking
Call Girls 🫤 Hauz Khas ➡️ 9999965857 ➡️ Delhi 🫦 Russian Escorts FULL ENJOY
Call Girls 🫤 Hauz Khas ➡️ 9999965857 ➡️ Delhi 🫦 Russian Escorts FULL ENJOY
Nicola Mining Inc. Corporate Presentation May 2024
Nicola Mining Inc. Corporate Presentation May 2024
Corporate Presentation Probe May 2024.pdf
Corporate Presentation Probe May 2024.pdf
VIP Amritsar Call Girl 7001035870 Enjoy Call Girls With Our Escorts
VIP Amritsar Call Girl 7001035870 Enjoy Call Girls With Our Escorts
(👉゚9999965857 ゚)👉 VIP Call Girls Friends Colony 👉 Delhi 👈 : 9999 Cash Payment...
(👉゚9999965857 ゚)👉 VIP Call Girls Friends Colony 👉 Delhi 👈 : 9999 Cash Payment...
Call Girls In Amritsar 💯Call Us 🔝 76967 34778🔝 💃 Independent Escort In Amritsar
Call Girls In Amritsar 💯Call Us 🔝 76967 34778🔝 💃 Independent Escort In Amritsar
Indapur - Virgin Call Girls Pune | Whatsapp No 8005736733 VIP Escorts Service...
Indapur - Virgin Call Girls Pune | Whatsapp No 8005736733 VIP Escorts Service...
Vip Call Girls South Ex ➡️ Delhi ➡️ 9999965857 No Advance 24HRS Live
Vip Call Girls South Ex ➡️ Delhi ➡️ 9999965857 No Advance 24HRS Live
Vip Call Girls Vasant Kunj ➡️ Delhi ➡️ 9999965857 No Advance 24HRS Live
Vip Call Girls Vasant Kunj ➡️ Delhi ➡️ 9999965857 No Advance 24HRS Live
Call Girls Chandigarh Just Call 8868886958 Top Class Call Girl Service Available
Call Girls Chandigarh Just Call 8868886958 Top Class Call Girl Service Available
Editing progress 20th march.docxxxxxxxxx
Editing progress 20th march.docxxxxxxxxx
Collective Mining | Corporate Presentation - April 2024
Collective Mining | Corporate Presentation - April 2024
Collective Mining | Corporate Presentation - May 2024
Collective Mining | Corporate Presentation - May 2024
Q3 2009 Earning Report of Walgreen Co.
1.
4th Quarter and
Fiscal Year 2009 Conference Call September 29, 2009 © Copyright 2009 Walgreen Co. 1
2.
Fourth Quarter and
Fiscal Year 2009 Agenda Introduction Rick Hans & Safe Harbor Divisional VP - IR & Finance 4Q and FY Highlights Greg Wasson & Strategies Update President & CEO 4Q and FY Financials Wade Miquelon Executive Vice President & CFO Questions & Answers All © Copyright 2009 Walgreen Co. 2
3.
Safe Harbor
Certain statements and projections of future results made in this presentation f t lt d i thi t ti constitute forward-looking information that is based on current market, competitive and regulatory expectations that involve risk and uncertainty. Please see our latest Forms 10-K and 10-Q for a discussion of factors as they relate to forward-looking statements. © Copyright 2009 Walgreen Co. 3
4.
4Q and FY09
Highlights & Strategies Update Greg Wasson President & CEO © Copyright 2009 Walgreen Co. 4
5.
Fourth Quarter Highlights
In $ Millions except EPS 4Q08 4Q09 Change Net Sales $14,597 $15,703 7.6% Net Earnings $443 $436* (1.5%) EPS, diluted $0.45 $0.44* (2.2%) Cash From Operations $548 $852 55.5% * Includes $33 million after-tax, or $.03 per diluted share, restructuring and restructuring-related costs. © Copyright 2009 Walgreen Co. 5
6.
Fiscal 2009 Highlights
In $ Millions except EPS FY08 FY09 Change Net Sales $59,034 $63,335 7.3% Net Earnings $2,157 $2,006* (7.0%) EPS, diluted $2.17 $2.02* (6.9%) Cash From Operations $3,039 $4,111 35.3% * Includes $163 million after-tax, or $.16 per diluted share, restructuring and restructuring-related costs. © Copyright 2009 Walgreen Co. 6
7.
On the Frontlines
of Healthcare Healthcare Reform Support need for healthcare reform Focus on prevention and wellness Employer funded medical coverage critical Employer-funded Provider of quality, affordable, accessible healthcare with 68,000 health professionals Update on flu season 16 000 16,000 certified immunizers Significant growth in seasonal flu shots Positioned for H1N1 pandemic © Copyright 2009 Walgreen Co. 7
8.
Taking Walgreen Co.
to the Market Co Platforms in place 7,000 drugstores Specialty pharmacy and infusion 700 worksite health centers and retail clinics Direct-to-employer/government/MCO/PBM Caterpillar – Proprietary, transparent price list Direct-to-consumer Prescription Savings Club – nearly 2M members © Copyright 2009 Walgreen Co. 8
9.
Consumers Respond to
90-Day at Retail % of 90-Day Prescriptions Promotes choice 5.0% 4.5% Drives adherence 4.0% Increases compliance 3.5% Improves outcomes 3.0% 2.5% Lowers costs 2.0% 2005 2006 2007 2008 2009 % = (# of 90-day Rx/(# of 30-day + 90-day Rx))x100 © Copyright 2009 Walgreen Co. 9
10.
Leveraging & Enhancing Our
Core Business Slowing store openings Re-inventing the customer experience Transforming community pharmacy Expanding health & wellness Expanding specialty pharmacy Broadening & deepening g p g payor relationships Rewiring for growth © Copyright 2009 Walgreen Co. 10
11.
Projected Net New
Store Openings 12% 10% Estimated 8% 6% 3% Growth 4% 2% 0% 2007 2008 2009 2010 2011 New store openings include new and relocated stores © Copyright 2009 Walgreen Co. 11
12.
SG&A Growth Declining
Ahead of Slowing Store Growth Store Added (including On-Site and 700 25% e Walgreen Rx Only stores) 600 20% 500 SG&A Growth Rate y 400 15% 300 10% ns 200 5% 100 es 0 0% FY99 FY00 FY01 FY02 FY03 FY04 FY05 FY06 FY07 FY08 FY09 Organic g Acquired q Adjusted for restructuring and restructuring-related costs © Copyright 2009 Walgreen Co. 12
13.
Reinventing the Customer
Experience 4Q09 Milestones – Rolling out CCR in 400 Texas stores – Rolling out convenience offering of beer and wine – Re launched walgreens com Re-launched walgreens.com 2008 2009 2010 3Q09 – Apr/May Fall ’09 – Sep/Oct 09 Calendar 2010 35-store CCR pilot CCR rollout in TX markets CCR rollout nationwide Category optimization Begin beer and wine rollout Loyalty initiative pilot Inventory improvements Re-launched Walgreens.com © Copyright 2009 Walgreen Co. 13
14.
the new walgreens
com walgreens.com © Copyright 2009 Walgreen Co. 14
15.
Cost Reductions &
Productivity Gains Year-over-Year Percent Increase 20% Gross Profit 15% SG&A 10% 5% 0% 2004 2005 2006 2007 2008 2009 SG&A adjusted for restructuring and restructuring-related costs in 1Q, 2Q, 3Q and 4Q 2009 Gross Profit adjusted for restructuring and restructuring-related costs in 2Q, 3Q, and 4Q 2009 © Copyright 2009 Walgreen Co. 15
16.
© Copyright 2009
Walgreen Co. 16
17.
4Q and FY09
Financial Review Wade Miquelon Executive VP and CFO © Copyright 2009 Walgreen Co. 17
18.
Fourth Quarter Highlights
4Q08 4Q09 Net Sales 8.8% 7.6% Net Earnings 11.7% (1.5%) EPS (Diluted) $0.45 $0.44* Prescriptions Sales ($) 7.9% 9.0% Total Prescriptions (#) 4.9%** 9.1%** p Comparable Prescription Sales 2.0% 4.5% Front-end Sales 3.7% (1.4%) Total Sales 2.6% 2 6% 2.4% 2 4% Rx Scripts 1.1%*** 5.9%*** *Includes $.03 per share, diluted, of restructuring and restructuring-related costs. **Includes **I l d 111 b i 4Q08 and 136 b i 4Q09 positive i bp in d bp in iti impact d t more patients filli 90 d prescriptions t due to ti t filling 90-day i ti ***Includes 118 bp in 4Q08 and 179 bp in 4Q09 positive impact due to more patients filling 90-day prescriptions © Copyright 2009 Walgreen Co. 18
19.
Fiscal Year 2009
Highlights FY08 FY09 Net Sales 9.8% 7.3% Net Earnings 5.7% (7.0%) EPS (Diluted) $2.17 $2.02* Prescriptions Sales ($) 9.7% 7.8% Total Prescriptions (#) 6.4%** 6.9%** p Comparable Prescription Sales 3.9% 3.5% Front-end Sales 4.2% (0.5%) Total Sales 4.0% 4 0% 2.0% 2 0% Rx Scripts 2.8%*** 3.6%*** *Includes $.16 per diluted share, of restructuring and restructuring-related costs. **Includes **I l d 64 b i FY08 and 137 b i FY09 positive i bp in d bp in iti impact d t more patients filli 90 d prescriptions t due to ti t filling 90-day i ti ***Includes 75 bp in FY08 and 173 bp in FY09 positive impact due to more patients filling 90-day prescriptions © Copyright 2009 Walgreen Co. 19
20.
Gross Profit Margin
4Q08 4Q09 Change Gross Profit Margin 27.6% 27.7% +10 bps Margin impacts + Positively impacted by retail pharmacy margins due to generics g - Partially offset by non-retail businesses, and lower FE margins d e to prod ct mi LIFO and due product mix, restructuring and restructuring-related costs © Copyright 2009 Walgreen Co. 20
21.
Percent Increase in
SG&A Dollars Two-year Stacked 30% 28.0% 25.5% % 24.9% 25% 23.4% 10.0% 20% 11.2% 10.2% 8.0% 18.6% 16.9% 16 9% 17.6% 17 6% 15% 8.6% 14.1% 5.7% 7.4% 10% 6.1% 18.0% 18 0% 14.3% 14.7% 15.4% 5% 10.0% 11.2% 10.2% 8.0% 0% 1Q07 2Q07 3Q07 4Q07 1Q08 2Q08 3Q08 4Q08 +1Q08 +2Q08 +3Q08 +4Q08 +1Q09 +2Q09 +3Q09 +4Q09 Note: SG&A data adjusted for vacation accrual in 4Q08 and restructuring and restructuring-related costs in 1Q, 2Q, 3Q and 4Q 2009. © Copyright 2009 Walgreen Co. 21
22.
Rewire for Growth
on Target $500 million pre-tax savings in FY10 $1 billion pre-tax savings in FY11 1Q09 2Q09 3Q09 4Q09 Savings $.01 $.02 $.06 $.07 Costs* ($.01) ($.06) ($.06) ($.03) Net $.00 ($.04) $.00 $.04 Savings *Restructuring and restructuring-related charges include impact of CCR markdown activity on gross profit margin Restructuring © Copyright 2009 Walgreen Co. 22
23.
Income Statement Details
4Q08 4Q09 LIFO Provision $24M $48M g Restructuring $51M SKU discontinuation $19M Consultants and other $23M Reduction in force $9M Net Interest Expense $7M $23M Tax Rate 37.1% 35.8% © Copyright 2009 Walgreen Co. 23
24.
Balance Sheet Highlights
4Q08 4Q09 Change Accounts Receivable $2.5B $2.5B (1.2%) Inventories $7.2B $6.8B ( (6.3%) ) Accounts Payable ($4.3B) ($4.3B) 0.4% Total $5.4B $5 4B $5.0B $5 0B (7.4%) (7 4%) Total as a % of Sales 37.0% 31.8% 14.1% © Copyright 2009 Walgreen Co. 24
25.
FIFO Inventory Trends
4Q08 1Q09 2Q09 3Q09 4Q09 Percent Change Total 7.2% 10.0% 4.6% (0.3%) (3.5%) Inventory I t Percent C Change Total g (2.2%) (2 2%) 0.1% 0 1% (4.0%) (4 0%) (9.1%) (9 1%) (11.1%) (11 1%) Inventory per Store* *Total FIFO inventory/total drugstore locations Total © Copyright 2009 Walgreen Co. 25
26.
Net Cash
1Q09 2Q09 3Q09 4Q09 Cash $886 $909 $2,300 $2,087 Short Term – $650 $100 $500 Investments Short Term Debt $1,081 $12 $10 $15 Long Term Debt $1,337 $2,332 $2,338 $2,336 Net Cash* ($1,532M) ($785M) $52M $236M *Net cash = cash and cash-equivalents plus short-term investments less short-term and long-term debt © Copyright 2009 Walgreen Co. 26
27.
Capital Expenditures
Dollars in Billions FY08 FY09 FY10E New Stores $1.6 $1.4 lower Existing Stores $0.3 $0.2 higher DCs $0.1 $0 1 $0.1 $0 1 lower IT & Other $0.2 $0.2 higher Total T t l $2.2 $2 2 $1.9 $1 9 ~$1.6 $1 6 © Copyright 2009 Walgreen Co. 27
28.
Cash Flow ($
in Millions) Cash Flow from Operations Free Cash Flow (From St t (F Statements of Cash Flows) t f C h Fl ) (FCF=Cash Flow from Operations – C E ) (FCF C h Fl f O ti CapEx) 1,500 1,500 2009 1,000 1,000 2009 2008 500 500 2008 0 0 -500 -500 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q © Copyright 2009 Walgreen Co. 28
29.
The Road Ahead
Opportunities – Executing our 3 core strategies – Significant growth and share gain – Aggressively investing in business model Challenges... Our Next Opportunities – Reimbursement pressure continues – Economic uncertainty © Copyright 2009 Walgreen Co. 29
30.
Questions & Answers
Q ti A © Copyright 2009 Walgreen Co. 30
31.
© Copyright 2009
Walgreen Co. 31
32.
Appendix © Copyright 2009
Walgreen Co. 32
33.
Calculation of Adjusted
SG&A: Restructuring Restr ct ring and Restructuring-Related Costs Restr ct ring Related Dollars in Millions 1Q08 1Q09 SGA under GAAP $ 3,193 $ 3,482 Less: Restructuring and g Restructuring-related Costs $ - $ 14 Adjusted SGA $ 3,193 $ 3,468 Adjusted YOY % Increase 8.6% © Copyright 2009 Walgreen Co. 33
34.
Calculation of Adjusted
Gross Profit: Restructuring Restr ct ring and Restructuring-Related Costs Restr ct ring Related Dollars in Millions 2Q08 2Q09 Gross Profit under GAAP $ 4,442 $ 4,657 Plus: Restructuring and g Restructuring-related Costs $ - $ 11 Adjusted Gross Profit $ 4,442 $ 4,668 Adjusted YOY % Increase 5.1% © Copyright 2009 Walgreen Co. 34
35.
Calculation of Adjusted
SG&A: Restructuring Restr ct ring and Restructuring-Related Costs Restr ct ring Related Dollars in Millions 2Q08 2Q09 SGA under GAAP $ 3,354 $ 3,627 Less: Restructuring and g Restructuring-related Costs $ - $ 82 Adjusted SGA $ 3,354 $ 3,545 Adjusted YOY % Increase 5.7% © Copyright 2009 Walgreen Co. 35
36.
Calculation of Adjusted
Gross Profit: Restructuring Restr ct ring and Restructuring-Related Costs Restr ct ring Related Dollars in Millions 3Q08 3Q09 Gross Profit under GAAP $ 4,245 $ 4,459 Plus: Restructuring and g Restructuring-related Costs $ - $ 65 Adjusted Gross Profit $ 4,245 $ 4,524 Adjusted YOY % Increase 6.6% © Copyright 2009 Walgreen Co. 36
37.
Calculation of Adjusted
SG&A: Restructuring Restr ct ring and Restructuring-Related Costs Restr ct ring Related Dollars in Millions 3Q08 3Q09 SGA under GAAP $ 3,331 $ 3,613 Less: Restructuring and g Restructuring-related Costs $ - $ 34 Adjusted SGA $ 3,331 $ 3,579 Adjusted YOY % Increase 7.4% © Copyright 2009 Walgreen Co. 37
38.
Calculation of Adjusted
Gross Profit: Restructuring Restr ct ring and Restructuring-Related Costs Restr ct ring Related Dollars in Millions 4Q08 4Q09 Gross Profit under GAAP $ 4,035 $ 4,346 Plus: Restructuring and g Restructuring-related Costs $ - $ 19 Adjusted Gross Profit $ 4,035 $ 4,365 Adjusted YOY % Increase 8.2% © Copyright 2009 Walgreen Co. 38
39.
Calculation of Adjusted
SG&A: Restructuring Restr ct ring and Restructuring-Related Costs Restr ct ring Related Dollars in Millions 4Q08 4Q09 SGA under GAAP $ 3,324 $ 3,644 Less: Restructuring and g Restructuring-related Costs $ - $ 32 Adjusted SGA $ 3,324 $ 3,612 Adjusted YOY % Increase 8.7% © Copyright 2009 Walgreen Co. 39
40.
Reconciliation of FIFO
Inventory: 4Q08 1Q09 2Q09 3Q09 4Q09 Total FIFO $8,316.3 $9,408.4 $8,742.2 $8,082.4 $8,028.7 Inventory LIFO Provision $1,067.3 $1,110.5 $1,158.7 $1,191.4 $1,239.4 O Total LIFO $7,249.0 $7 249 0 $8,297.9 $8 297 9 $7,583.5 $7 583 5 $6,891.0 $6 891 0 $6,789.3 $6 789 3 Inventory © Copyright 2009 Walgreen Co. 40
41.
Calculation of Free
Cash Flow: 1Q08 2Q08 3Q08 4Q08 1Q09 2Q09 3Q09 4Q09 Cash Flow from Operations $390 $1,116 $985 $548 $312 $1,428 $1,519 $852 under GAAP Capital Expenditures ($490) ($553) ($610) ($572) ($638) ($454) ($442) ($393) under GAAP Free Cash Flow non-GAAP ($100) $563 $375 ($24) ($326) $974 $1,077 $459 measure © Copyright 2009 Walgreen Co. 41
Descargar ahora